Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study

(2018) Hiroshi Maegawa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients

(2018) Nobuya Inagaki et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

(2018) Mikhail Kosiborod et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study

(2017) Ichiro Nakamura et al.   EXPERT OPINION ON PHARMACOTHERAPY

Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

(2016) Hiroshi Maegawa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials

(2016) Atsunori Kashiwagi et al.   Journal of Diabetes Investigation

Water and Beverage Consumption: Analysis of the Australian 2011–2012 National Nutrition and Physical Activity Survey

(2016) Zhixian Sui et al.   Nutrients

A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Dia

(2015) A. Kashiwagi et al.   DIABETES OBESITY & METABOLISM

Association of Body Mass Index and Mortality in Japanese Diabetic Men and Women Based on Self-Reports: The Japan Collaborative Cohort (JACC) Study

(2015) Yasuhiko Kubota et al.   JOURNAL OF EPIDEMIOLOGY

Relation between BMI and Diabetes Mellitus and Its Complications among US Older Adults

(2015) Natallia Gray et al.   SOUTHERN MEDICAL JOURNAL

The threshold shift paradigm of obesity: evidence from surgically induced weight loss

(2014) Ele Ferrannini et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study

(2014) A. Kashiwagi et al.   DIABETES OBESITY & METABOLISM

The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States

(2014) Michael L Ganz et al.   Diabetology & Metabolic Syndrome

Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

(2013) Ronald C.W. Ma et al.   Annals of the New York Academy of Sciences

Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus

(2013) Atsunori Kashiwagi et al.   Journal of Diabetes Investigation

Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus

(2012) Muhammad A. Abdul-Ghani et al.   Current Diabetes Reports

Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?

(2011) Robert H. Eckel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

SGLT2 inhibitors: molecular design and potential differences in effect

(2011) Masayuki Isaji   KIDNEY INTERNATIONAL

Body Mass Index and Diabetes in Asia: A Cross-Sectional Pooled Analysis of 900,000 Individuals in the Asia Cohort Consortium

(2011) Paolo Boffetta et al.   PLoS One

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

(2009) Daphne P Guh et al.   BMC PUBLIC HEALTH